This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday
Fortinet, Inc.
Axsome Therapeutics, Inc.
American Healthcare REIT, Inc.
Eledon Pharmaceuticals, Inc.
Trevi Therapeutics
Fortinet, Inc. FTNT | 0.00 | |
Axsome Therapeutics, Inc. AXSM | 0.00 | |
American Healthcare REIT, Inc. AHR | 0.00 | |
Eledon Pharmaceuticals, Inc. ELDN | 0.00 | |
Trevi Therapeutics TRVI | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Morgan Stanley analyst Meta Marshall upgraded Fortinet Inc (NASDAQ:FTNT) from Underweight to Equal-Weight and raised the price target from $80 to $133. Fortinet shares closed at $160.36 on Monday. See how other analysts view this stock.
- HSBC analyst Saul Martinez upgraded The Goldman Sachs Group, Inc. (NYSE:GS) from Reduce to Hold and raised the price target from $834 to $995. Goldman Sachs shares closed at $1,055.03 on Monday. See how other analysts view this stock.
- Jefferies analyst Brian Tanquilut upgraded Adaptive Biotechnologies Corporation (NASDAQ:AHCO) from Hold to Buy and raised the price target from $11 to $13. AdaptHealth shares closed at $21.86 on Monday. See how other analysts view this stock.
- Bernstein analyst Zhihan Ma upgraded Five Below, Inc. (NASDAQ:FIVE) from Market Perform to Outperform and boosted the price target from $247 to $250. Five Below shares closed at $204.14 on Monday. See how other analysts view this stock.
Considering buying FTNT stock? Here’s what analysts think:
Photo via Shutterstock